News
Draft Pandemic Accord Has IP Waivers, Pathogen Sharing Perks
The draft pandemic accord, which was sent to member states of the World Health Organisation by the Intergovernmental Negotiating Body recently, includes several important elements. One of these is the provision for time-bound waivers when it comes to intellectual...
News
Greater Pharma & Tech COs Ties Can Drive Innovation Further
Big tech along with Big Pharma have gone on to play a crucial role in elevating standards of living as well as shaping the modern age.
Over the course of several decades, both big pharma and big tech have heavily relied on...
BioPharma
CDMO-Biotech Collab Diminish Business Risk In Drug Creation
Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced industry. The astronomically high costs, complicated manufacturing processes, as well as regulatory hurdles related to biologics can go on...
IT & Data Management
Medical Drone Delivery Segment To Be Kept Close Eyes On
The healthcare industry is experiencing prominent changes because of the rapid advancement of tech. Artificial intelligence- AI is already playing a pivotal role in drug delivery and is also utilised across the manufacturing sector. Digital health has quickly emerged...
News
How To Get Off Drugs Safely
Dealing with drug and substance abuse can cause a lot of issues. Many people struggle with drug addiction, whether this is to illegal or legal substances, which can ruin their health and wellbeing.
Addiction is not something you can deal...
News
Workforce Training To Improve APAC Response To The Pandemic
The Ministry of Health and Welfare in South Korea has gone on to announce a collaborative effort with the Asian Development Bank to carry out a joint training programme.
The idea of this programme is to boost vaccine manufacturing capacity...
Clinical Trials
MHRA Rolls Out New Scheme For Lowest-Risk UK Clinical Trials
The Medicines and Healthcare products Regulatory Agency has gone on to launch a new scheme that seeks to lessen the nod time when it comes to clinical trials in the UK that are at lowest risk by more than 50%.
The novel...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















